Charles River Labs (CRL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

leverages changes in earnings projections to function as a reliable gauge for predicting short-term stock price movements. Charles River currently has a Zacks Rank #3 (Hold), indicating that it could ...

CLSA has recently initiated Charles River Lbrtrs ntrntl Inc (CRL) stock to Underperform rating, as announced on October 23, 2024, according to Finviz. Earlier, on October 14, 2024, Redburn Atlantic ...

Charles River Labs (CRL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant from Morgan Stanley maintained a Hold rating on the ...

New York State Teachers Retirement System trimmed its stake in Charles River Laboratories International, Inc. (NYSE:CRL – ...

Overall, analysts' consensus view on Charles River Laboratories stock is cautious, with a "Hold" rating. Out of 17 analysts covering the stock, five recommend a "Strong Buy," 10 suggest a "Hold ...

Charles River Laboratories (CRL) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.72 per share a year ago.

Charles River Laboratories International Inc CRL reported ... Price Action: At last check on Wednesday, CRL stock was up 14% at $215.10.

The company also repurchased $100.7 million worth of shares as part of a $1.0 billion stock repurchase authorization, with $899.3 million remaining. Looking ahead, Charles River Laboratories ...

WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the ...